Alzheimer’s Disease Variant Portal (ADVP): The Newest Curated Population-specific Alzheimer’s Disease Genetics Resource

By Fernanda Ruiz, NOVA Research Company Alzheimer’s Disease (AD) is a devastating disease that affects more than 6 million Americans, a number that is projected to increase considerably in the near future. Scientists looking for the causes of AD use different approaches, including genomic studies like genome-wide association studies (GWAS), that detect associations between genetic […]

Structural Variant Toolbox: Discovering, Genotyping, and Merging SVs in Alzheimer’s Disease Research

By Fernanda Ruiz, NOVA Research Company Alzheimer’s disease (AD) is a degenerative disease that likely is caused by a combination of environmental, lifestyle, and genetic factors, and increasing age. Alzheimer’s Disease Sequencing  Project (ADSP) researchers are focused on gaining further insights into the genetic component of this disease, including the role of structural variants (SVs), […]

CADRE/ADGC Announce Trans-Institutional Seminar Series

The Collaborative for Alzheimer’s Disease Research (CADRE) and the Alzheimer’s Disease Genetics Consortium (ADGC) are creating a new multi-institutional seminar series to support next generation researchers in Alzheimer’s disease process, diagnosis and care by encouraging collaboration within the AD research community. The new Trans-Institutional Seminar Series will highlight up-and-coming junior investigators to help strengthen their […]

Alessandra Chesi, PhD: Advancing Toward Druggable Targets

By Kathy Sedgwick, NOVA Research Company Dr. Alessandra Chesi joined the University of Pennsylvania faculty as an Assistant Professor of Pathology and Laboratory Medicine in July 2020. Her work at Penn focuses on the application of transformative technologies as well as functional genomics and systems biology approaches toward gaining insight into the regulation and identity […]

Sign up to receive journal club/seminar announcements